Back
Freeport-McMoRan Vs. Blueprint Medicines Industry Stock Comparison
Buy
61
FCX
Freeport-McMoRan
Last Price:
$45.20
Seasonality Move:
0.89%
Buy
53
BPMC
Blueprint Medicines
Last Price:
$129.46
Seasonality Move:
1.87%
Buy
61
Freeport-McMoRan (FCX)
is a Buy
Is Freeport-McMoRan a Buy, Sell or Hold?
-
The current Freeport-McMoRan [FCX] share price is $44.80. The Score for FCX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
FCX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $129.46. The Score for BPMC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FCX Stock Price Chart
What is Freeport-McMoRan's stock price today?
-
The Freeport-McMoRan share price today is $44.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $129.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
FCX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 12.44 | Buy |
Relative Strength Index (14 RSI): | 55.81 | Buy |
Chaikin Money Flow: | 8430325 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.66 - 45.72) | Buy |
Bollinger Bands (100): | (35.21 - 42.89) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.64 | Buy |
Relative Strength Index (14 RSI): | 76.66 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.05 - 129.07) | Buy |
Bollinger Bands (100): | (85.56 - 121.94) | Buy |
FCX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.27 | Sell |
20-day SMA: | 44.28 | Buy |
50-day SMA: | 41.53 | Buy |
200-day SMA: | 40.92 | Buy |
8-day EMA: | 40.25 | Buy |
20-day EMA: | 26.83 | Buy |
50-day EMA: | 13.7 | Buy |
200-day EMA: | 3.9 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.26 | Buy |
20-day SMA: | 128.67 | Buy |
50-day SMA: | 118.77 | Buy |
200-day SMA: | 99.63 | Buy |
8-day EMA: | 129.2 | Buy |
20-day EMA: | 127.73 | Buy |
50-day EMA: | 119.71 | Buy |
200-day EMA: | 103.46 | Buy |
Freeport-McMoRan Earnings Growth & FCX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.23 per share, an increase this year of $0.36 per share, and an increase next year of $0.73 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.56 per share, an increase next quarter of $0.44 per share, an increase this year of $0.60 per share, and an increase next year of $0.94 per share.
Freeport-McMoRan Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |